Legis Daily

Drug Price Transparency in Medicaid Act of 2019

USA116th CongressHR-5281| House 
| Updated: 12/4/2019
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Tony Cárdenas (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug Price Transparency in Medicaid Act of 2019 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 3, 2019
Introduced in House
Dec 3, 2019
Referred to the House Committee on Energy and Commerce.
Dec 4, 2019
Referred to the Subcommittee on Health.
  • December 3, 2019
    Introduced in House


  • December 3, 2019
    Referred to the House Committee on Energy and Commerce.


  • December 4, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 116-2543: Prescription Drug Pricing Reduction Act of 2019
  • HR 116-3: Elijah E. Cummings Lower Drug Costs Now Act
  • S 116-4199: Prescription Drug Pricing Reduction Act of 2020
  • HR 116-19: Lower Costs, More Cures Act of 2019
Business recordsCongressional oversightGovernment information and archivesHealth care costs and insuranceHome and outpatient careInflation and pricesMedicaidPrescription drugsPublic contracts and procurementRetail and wholesale tradesState and local government operationsUser charges and fees

Drug Price Transparency in Medicaid Act of 2019

USA116th CongressHR-5281| House 
| Updated: 12/4/2019
Drug Price Transparency in Medicaid Act of 2019 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 3, 2019
Introduced in House
Dec 3, 2019
Referred to the House Committee on Energy and Commerce.
Dec 4, 2019
Referred to the Subcommittee on Health.
  • December 3, 2019
    Introduced in House


  • December 3, 2019
    Referred to the House Committee on Energy and Commerce.


  • December 4, 2019
    Referred to the Subcommittee on Health.
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Tony Cárdenas (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-2543: Prescription Drug Pricing Reduction Act of 2019
  • HR 116-3: Elijah E. Cummings Lower Drug Costs Now Act
  • S 116-4199: Prescription Drug Pricing Reduction Act of 2020
  • HR 116-19: Lower Costs, More Cures Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsCongressional oversightGovernment information and archivesHealth care costs and insuranceHome and outpatient careInflation and pricesMedicaidPrescription drugsPublic contracts and procurementRetail and wholesale tradesState and local government operationsUser charges and fees